| Product NDC: | 0009-5136 |
| Proprietary Name: | Zyvox |
| Non Proprietary Name: | linezolid |
| Active Ingredient(s): | 100 mg/5mL & nbsp; linezolid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-5136 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021132 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000418 |
| Package NDC: | 0009-5136-01 |
| Package Description: | 240 mL in 1 BOTTLE (0009-5136-01) |
| NDC Code | 0009-5136-01 |
| Proprietary Name | Zyvox |
| Package Description | 240 mL in 1 BOTTLE (0009-5136-01) |
| Product NDC | 0009-5136 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | linezolid |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20000418 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | LINEZOLID |
| Strength Number | 100 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient] |